Chemical activators of Svs3a can initiate a cascade of intracellular events leading to the protein's activation. Forskolin is known to directly stimulate adenylyl cyclase, which catalyzes the conversion of ATP to cyclic AMP (cAMP). The increase in cAMP levels subsequently activates protein kinase A (PKA), a kinase that can directly phosphorylate Svs3a, leading to its activation. Similarly, Ionomycin acts by increasing intracellular calcium levels, which then activate calcium-dependent kinases capable of phosphorylating and activating Svs3a. Phorbol 12-myristate 13-acetate (PMA) directly activates protein kinase C (PKC), another kinase that can phosphorylate Svs3a, resulting in its activation. Insulin works through the activation of the PI3K/Akt pathway, a signaling route that culminates in the phosphorylation and activation of various proteins, including Svs3a.
In addition to these, Epinephrine engages adrenergic receptors which increase intracellular levels of cAMP, leading to the activation of PKA that can phosphorylate Svs3a. IBMX functions by inhibiting phosphodiesterases, thereby preventing the breakdown of cAMP and enhancing PKA activity, which in turn activates Svs3a. Okadaic Acid and Calyculin A both inhibit protein phosphatases, which normally dephosphorylate proteins, thereby maintaining Svs3a in an active phosphorylated state. Another compound, Anisomycin, activates stress-activated protein kinases that can also lead to the phosphorylation and activation of Svs3a. H-89, under certain conditions, can paradoxically increase cAMP levels, thus activating PKA and promoting the phosphorylation and consequent activation of Svs3a. Zaprinast inhibits phosphodiesterase 5, leading to increased cAMP levels and the activation of PKA, which can then activate Svs3a. Lastly, Dibutyryl-cAMP (db-cAMP), a stable analog of cAMP, directly activates PKA, resulting in the phosphorylation of Svs3a. Through these diverse yet interconnected pathways, each chemical can lead to the functional activation of Svs3a by influencing different kinases and phosphatases that modulate its phosphorylation state.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Ionomycin | 56092-82-1 | sc-3592 sc-3592A | 1 mg 5 mg | $78.00 $270.00 | 80 | |
Increases intracellular Ca²⁺, activating calcium-dependent kinases that could phosphorylate and activate Svs3a. | ||||||
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
Activates PKC, which can phosphorylate and activate Svs3a. | ||||||
Insulin | 11061-68-0 | sc-29062 sc-29062A sc-29062B | 100 mg 1 g 10 g | $156.00 $1248.00 $12508.00 | 82 | |
Activates PI3K/Akt pathway resulting in the phosphorylation and activation of Svs3a. | ||||||
(−)-Epinephrine | 51-43-4 | sc-205674 sc-205674A sc-205674B sc-205674C sc-205674D | 1 g 5 g 10 g 100 g 1 kg | $41.00 $104.00 $201.00 $1774.00 $16500.00 | ||
Engages adrenergic receptors increasing cAMP levels, activating PKA which then phosphorylates and activates Svs3a. | ||||||
IBMX | 28822-58-4 | sc-201188 sc-201188B sc-201188A | 200 mg 500 mg 1 g | $260.00 $350.00 $500.00 | 34 | |
Inhibits phosphodiesterases leading to increased cAMP and consequent activation of PKA and Svs3a. | ||||||
Okadaic Acid | 78111-17-8 | sc-3513 sc-3513A sc-3513B | 25 µg 100 µg 1 mg | $291.00 $530.00 $1800.00 | 78 | |
Inhibits protein phosphatases keeping proteins like Svs3a in a phosphorylated and active state. | ||||||
Anisomycin | 22862-76-6 | sc-3524 sc-3524A | 5 mg 50 mg | $99.00 $259.00 | 36 | |
Activates stress-activated protein kinases which can phosphorylate and activate Svs3a. | ||||||
Calyculin A | 101932-71-2 | sc-24000 sc-24000A | 10 µg 100 µg | $163.00 $800.00 | 59 | |
Inhibits protein phosphatases preserving the phosphorylation and activation state of Svs3a. | ||||||
Zaprinast (M&B 22948) | 37762-06-4 | sc-201206 sc-201206A | 25 mg 100 mg | $105.00 $250.00 | 8 | |
Inhibits phosphodiesterase 5, increasing cAMP which activates PKA, leading to the phosphorylation and activation of Svs3a. | ||||||
Dibutyryl-cAMP | 16980-89-5 | sc-201567 sc-201567A sc-201567B sc-201567C | 20 mg 100 mg 500 mg 10 g | $47.00 $136.00 $492.00 $4552.00 | 74 | |
A cAMP analog that activates PKA leading to the phosphorylation and activation of Svs3a. | ||||||